Dr. K. Sabitha
Managing DirectorCiencia Life Sciences, India
Highest Degree
Ph.D. in Biotechnology from Jawaharlal Nehru Technological University, India
Share this Profile
Area of Interest:
Selected Publications
- Sabitha, K. and K. Jamil, 2010. CYP1A1 polymorphisims and risk of Head and Neck cancer in relation to tobacco smoking. Cancer Epidemiol., 34: 587-592.
- Sabitha, K., M.V. Reddy and M.K. Jamil, 2009. Mutations in XRCC1 gene alters the genetic risks of head and neck cancer patients. Int. J. Cancer Res., 5: 58-68.
CrossRef | Direct Link | - Sabitha, K., M.V.V. Reddy and K. Jamil, 2008. GST genotypes in head and neck cancer patients and its clinical implications. Afr. J. Biotechnol., 7: 3853-3859.
- Sabitha, K. and K. Jamil, 2008. Evaluation of antioxidant enzymes and DNA damage as in squamous cell Carcinoma of the head and neck Cancers. Technol. Spectr., 2: 34-39.
- Kotra, S., K.K. Madala and K. Jamil, 2008. Homology models of the mutated EGFR and their response towards quinazolin analogues. J. Mol. Graphics Modeling, 27: 244-254.
CrossRef | PubMed | Direct Link | - Suman, G., K. Sabitha and K. Jamil, 2006. Mutations in MEXR leading to drug resistant in corneal keretites of humans. Indi. J. Exp. Biol., 44: 929-993.
- Sabitha, K. and J. Kaiser, 2006. Analysis of EGFR gene mutations which have a response to quinazolin inhibitors. Comp. Evol. Genomics Proteomics, 3: 229-232.